Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.45 |
| ▸ | CA1 | P00915 | 3/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.45 |
| ▸ | CA7 | P43166 | 3/20 | 0.45 |
| ▸ | CA9 | Q16790 | 3/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9460596 | 0.88 | CYP1A2 (0.48) | CYP1A2TSHRPDE4DALDH1A1HPGD | |
| SCHEMBL4827391 | 0.84 | CYP1A2 (0.48) | CYP1A2TSHRPDE4DALDH1A1HPGD | |
| SCHEMBL1311416 | 0.83 | MTOR (0.45) | CYP1A2TSHRPDE4DALDH1A1HPGD | |
| SCHEMBL15615316 | 0.81 | KMT2A (0.48) | CYP1A2ALDH1A1CA12CA1CA2 | |
| SCHEMBL15498679 | 0.81 | PDE4D (0.50) | CYP1A2PDE4DALDH1A1HPGDKDM4E | |
| SCHEMBL17705862 | 0.80 | ALDH1A1 (0.52) | TSHRALDH1A1HPGDKDM4EPOLB | |
| SCHEMBL577793 | 0.80 | ALDH1A1 (0.52) | CYP1A2ALDH1A1HPGDKDM4EPOLB | |
| SCHEMBL21174188 | 0.80 | CA12 (0.47) | CYP1A2TSHRALDH1A1KDM4EPOLB | |
| SCHEMBL9866873 | 0.80 | CYP1A2 (0.46) | CYP1A2TSHRKDM4EPOLBCA12 | |
| SCHEMBL6855288 | 0.80 | KMT2A (0.54) | CYP1A2PDE4DALDH1A1HPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105037374-A | Preparation method of N-butyl-9H-pyrido[4,5-b]indole-2-carboxamide | UNIV JILIN | 2015-11-11 | — | — | CN | claimed |
| US-4990429-A | Process for the production of negative relief copies utilizing reversal processing | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-02-05 | — | — | US | claimed |
| JP-2286676-A | — | — | None | — | — | JP | disclosed |
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-09-30 | — | — | US | disclosed |
| US-20240409753-A1 | WATER-/OIL-REPELLENT AGENT | DAIKIN INDUSTRIES, LTD. (JP) | 2024-12-12 | — | — | US | disclosed |
| EP-4471208-A1 | WATER-/OIL-REPELLENT AGENT | DAIKIN INDUSTRIES, LTD. (JP) | 2024-12-04 | — | — | EP | disclosed |
| EP-4313986-A1 | PROCESSES FOR MAKING BICYCLIC KETONE COMPOUNDS | Genentech, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| US-20240034739-A1 | PROCESSES FOR MAKING BICYCLIC KETONE COMPOUNDS | GENENTECH, INC. (US) | 2024-02-01 | — | — | US | disclosed |
| CN-117098762-A | Process for preparing bicyclic ketone compounds | 基因泰克公司 | 2023-11-21 | — | — | CN | disclosed |
| WO-2023167002-A1 | WATER-/OIL-REPELLENT AGENT | ダイキン工業株式会社 | 2023-09-07 | — | — | WO | disclosed |
| US-11566168-B1 | Biocide blend for treating wellbores | HALLIBURTON ENERGY SERVICES, INC. (US) | 2023-01-31 | — | — | US | disclosed |
| US-6077954-A | COMPOUNDS ARE CONSTRUCTED TO INCLUDE A CENTRAL AROMATIC, ALIPHATIC, OR HETEROCYCLIC RING SYSTEM. ATTACHED TO THE CENTRAL RING SYSTEM ARE TWO LINEAR GROUPS HAVING NITROGENOUS MOIETIES THAT ARE DERIVATIZED WITH CHEMICAL FUNCTIONAL GROUPS. | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-20 | — | — | US | disclosed |
| WO-1998010286-A1 | METHODS FOR PROCESSING CHEMICAL COMPOUNDS HAVING REACTIVE FUNCTIONAL GROUPS | ISIS PHARMACEUTICALS, INC. (US) | 1998-03-12 | — | — | WO | disclosed |
| WO-1998005961-A1 | COMPOUNDS HAVING A PLURALITY OF NITROGENOUS SUBSTITUENTS | ISIS PHARMACEUTICALS, INC. (US) | 1998-02-12 | — | — | WO | disclosed |
| EP-0817787-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030377-A1 | NITROGENOUS MACROCYCLIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 1996-10-03 | — | — | WO | disclosed |
| EP-0389432-B1 | Hindered amine derivatives of triazine and hexahydrotriazine | CIBA GEIGY AG (CH) | 1994-09-21 | — | — | EP | disclosed |
| US-5021483-A | Light stabilizers | CIBA-GEIGY CORPORATION (US) | 1991-06-04 | — | — | US | disclosed |
| JP-H02286676-A | HINDERED AMINE DERIVATIVE OF TRIAZINE OR HEXAHYDROTRIAZINE | CIBA GEIGY AG | 1990-11-26 | — | — | JP | disclosed |
| EP-0389432-A2 | Hindered amine derivatives of triazine and hexahydrotriazine | CIBA-GEIGY AG (CH) | 1990-09-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12427506-B1 | Method for carbon dioxide fixation using a palladium-doped nitrogen-rich organic framework catalyst | POF1B, CYP4F12, ETFB | CYP1A2 584/4885TSHR 2386/4885PDE4D 4540/4885 |
| US-11566168-B1 | Biocide blend for treating wellbores | KAT2B, WEE2, OTUB1 | CYP1A2 2548/4885TSHR 4072/4885PDE4D 1873/4885 |
| US-20240034739-A1 | PROCESSES FOR MAKING BICYCLIC KETONE COMPOUNDS | HSD17B7, BCKDK, CYP11B1 | CYP1A2 62/4885TSHR 2458/4885PDE4D 3627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.